Get In Touch

Leprosy is a chronic infectious disease caused by Mycobacterium leprae or Mycobacterium lepromatous. Leprosy is also known as Hansen’s disease. It primarily affects the nerves, the skin, the eyes, mucosa (of the mouth, the nose, and the pharynx), the kidneys, the testes, the reticulo-endothelial system, and the voluntary smooth muscles of the human body. Signs of leprosy can be easily identified. These include skin lesions with no sensation and thickened or damaged nerves. Leprosy can be broadly classified into paucibacillary leprosy and multibacillary leprosy. Moreover, leprosy patients with negative smear test at all sites are said to have paucibacillary leprosy (few skin lesions with or without the involvement of peripheral nerves). Those with positive smear test at any site are said to have multibacillary leprosy (multiple skin lesions in addition to nasal bleeding and edema at feet).

According to the World Health Organization (WHO), the global prevalence and incidence of leprosy was 176,176 cases and 211, 973 cases respectively, at end 2015. Leprosy is most prevalent in low-income countries. Treatment by using one anti-leprosy drug (monotherapy) is likely to result in the development of drug resistance by bacteria toward that drug. Thus, multidrug therapy (MDT) is a standard treatment for leprosy. Multidrug therapy was first recommended by the World Health Organization (WHO) Expert Committee in 1984. The WHO has been supplying MDT free of cost to all endemic countries since 1995. Rifampicin is the most commonly used antileprotic agent. It is effective in both types of leprosy. The WHO recommends multidrug combination of rifampicin, clofazimine, and dapsone for the treatment of multibacillary leprosy, whereas paucibacillary leprosy is treated with rifampicin and dapsone. Recently, some clinical trials have shown that certain quinolones such as ofloxacin, azithromycin, and minocycline are active against Mycobacterium leprae. The WHO has recently recommended single-dose treatment with minocycline, rifampin, or ofloxacin in patients with paucibacillary leprosy.

Rising prevalence of leprosy and expanding pool of patients suffering from leprosy all over the world and new treatment options are projected to drive the global leprosy treatment market during the forecast period. In addition to this, emergence of new technologies, favorable government initiatives, and availability of favorable reimbursement policies for high-cost therapies are projected to drive the leprosy treatment market in the near future. However, developing economies with low health care expenditure and least availability of medical facilities for proper diagnosis of diseases are projected to restrain the leprosy treatment market in developing countries during the forecast period.

The global leprosy treatment market can be segmented based on disease type, drug type, distribution channel, and region. Based on disease type, the global leprosy treatment market can be categorized into paucibacillary leprosy and multibacillary leprosy. Based on drug type, the market can be classified into phenazine derivatives, sulfone derivatives, anti-tubercular drugs, and others. Based on distribution channel, the global market can be segmented into online pharmacies, retail pharmacies, and hospital pharmacies.

Geographically, the global leprosy treatment market can be divided into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America is expected to hold the largest share of the global market from 2018 to 2026, due to favorable reimbursement scenario, high expenditure on health care, and rapid adoption of new technologies in the region. Europe is expected to be the second-largest market for leprosy treatment during the forecast period, due to rising awareness about new treatment options and high disposable income of people in the region. The Asia Pacific leprosy treatment market is expected to expand rapidly during the forecast period. Growth of the market in the region can be attributed to rising prevalence of leprosy, increasing government initiatives, and rapidly developing health care infrastructure in the region. As per National Health profile 2017, about 79,000 leprosy cases were detected in India (Asia Pacific) only. According to a report published by the Leprosy Mission Trust in 2014, the rate of prevalence of leprosy in India was about 0.68 per 10,000 people.

Key players operating in the global leprosy treatment market are GlaxoSmithKline plc, Macleods Pharmaceuticals, Cadila Pharmaceuticals, Novartis AG, Systopic Laboratories Pvt. Ltd., AstraZeneca plc, Zydus Cadila, Merck & Co., Inc., and Sanofi.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Leprosy Treatment Market

Pre Book